Does MEPOLIZUMAB Cause C-reactive protein abnormal? 305 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 305 reports of C-reactive protein abnormal have been filed in association with MEPOLIZUMAB (Nucala). This represents 0.7% of all adverse event reports for MEPOLIZUMAB.
305
Reports of C-reactive protein abnormal with MEPOLIZUMAB
0.7%
of all MEPOLIZUMAB reports
298
Deaths
297
Hospitalizations
How Dangerous Is C-reactive protein abnormal From MEPOLIZUMAB?
Of the 305 reports, 298 (97.7%) resulted in death, 297 (97.4%) required hospitalization, and 293 (96.1%) were considered life-threatening.
Is C-reactive protein abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MEPOLIZUMAB. However, 305 reports have been filed with the FAERS database.
What Other Side Effects Does MEPOLIZUMAB Cause?
Asthma (11,033)
Dyspnoea (9,192)
Wheezing (6,093)
Product dose omission issue (5,873)
Cough (4,577)
Pneumonia (4,107)
Therapeutic product effect incomplete (4,106)
Drug ineffective (3,880)
Loss of personal independence in daily activities (3,566)
Fatigue (2,656)
What Other Drugs Cause C-reactive protein abnormal?
METHOTREXATE (3,734)
ADALIMUMAB (3,629)
ETANERCEPT (3,592)
ABATACEPT (3,402)
LEFLUNOMIDE (3,279)
TOCILIZUMAB (3,259)
HYDROXYCHLOROQUINE (3,245)
SULFASALAZINE (2,823)
INFLIXIMAB (2,676)
RITUXIMAB (2,608)
Which MEPOLIZUMAB Alternatives Have Lower C-reactive protein abnormal Risk?
MEPOLIZUMAB vs MEPROBAMATE
MEPOLIZUMAB vs MERCAPTOPURINE
MEPOLIZUMAB vs MEROPENEM
MEPOLIZUMAB vs MEROPENEM ANHYDROUS
MEPOLIZUMAB vs MESALAMINE